Cytokine-induced killer cells
Sponsors
Sun Yat-sen University, Washington University School of Medicine, Yanjuan Zhu, The First People's Hospital of Changzhou, Henan Cancer Hospital
Conditions
Adenocarcinoma of LungAdvanced CancerBladder CancerCarcinoma, HepatocellularCervical CancerCholangiocarcinomaColonic NeoplasmsColorectal Cancer
Phase 1
Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
TerminatedNCT01898793
Start: 2014-08-11End: 2022-04-04Updated: 2024-01-17
Study of DC-CTL Combined With CIK for Advanced Solid Tumor
NCT03047525
Start: 2017-02-20End: 2020-12-01Target: 200Updated: 2017-02-09
Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells
NCT05108077
Start: 2022-03-01End: 2023-12-31Target: 20Updated: 2022-01-14
Phase 2
Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer
NCT01929499
Start: 2013-09-30End: 2019-08-31Target: 210Updated: 2013-08-29
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases
CompletedNCT02419677
Start: 2010-01-31End: 2014-12-31Updated: 2015-04-17
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
Active, not recruitingNCT02482454
Start: 2012-07-31End: 2033-07-31Updated: 2017-08-01
The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer
Active, not recruitingNCT02485015
Start: 2015-06-30End: 2033-06-30Updated: 2016-02-19
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma
Active, not recruitingNCT02487693
Start: 2015-07-31End: 2040-06-30Target: 50Updated: 2016-02-23
The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer
Active, not recruitingNCT02487992
Start: 2015-07-31End: 2045-07-31Target: 1200Updated: 2016-02-24
CIK in Treating Patients With Bladder Cancer
Active, not recruitingNCT02489890
Start: 2016-02-29End: 2030-07-31Target: 1500Updated: 2016-02-22
CIK in Treating Patients With Esophageal Cancer
Not yet recruitingNCT02490735
Start: 2015-08-31End: 2042-08-31Target: 2000Updated: 2015-07-07
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer
Active, not recruitingNCT02490748
Start: 2015-07-31End: 2040-06-30Updated: 2016-02-23
The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR
Active, not recruitingNCT02493582
Start: 2015-07-31End: 2033-07-31Target: 400Updated: 2016-02-05
Cytokine-induced Killer Study for Patients With Stage II Melanoma
Not yet recruitingNCT02498756
Start: 2015-08-31End: 2040-08-31Target: 300Updated: 2015-07-15
Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer
TerminatedNCT03002831
Start: 2016-11-30End: 2019-10-31Updated: 2020-04-02